+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Capillary Columns for Biopharmaceuticals Market by Application, End User, Column Type, Particle Size, Column Length, Stationary Phase - Global Forecast 2025-2030- Product Image
Capillary Columns for Biopharmaceuticals Market by Application, End User, Column Type, Particle Size, Column Length, Stationary Phase - Global Forecast 2025-2030- Product Image
New

Capillary Columns for Biopharmaceuticals Market by Application, End User, Column Type, Particle Size, Column Length, Stationary Phase - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 180 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6138909
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Pioneering Precision in Biopharmaceutical Capillary Column Analysis to Accelerate Drug Development Through Enhanced Separation Performance

Capillary columns have become indispensable tools in biopharmaceutical laboratories worldwide, offering unparalleled resolution and sensitivity for complex molecule separations. As drug discovery and development pipelines grow increasingly intricate, the precision and reliability of capillary column technology play a central role in ensuring analytical rigor and reproducibility. From early-stage biomarker identification to late-stage quality assurance, these columns underpin critical decisions in both academic research settings and commercial manufacturing environments.

In recent years, advancements in stationary phase chemistry, column geometry, and high-pressure instrumentation have collectively elevated the capabilities of capillary columns. This has enabled tighter control of peak shape, enhanced throughput, and improved detection limits. Simultaneously, the integration of automated sampling systems and advanced data analytics platforms has optimized workflows, minimized manual intervention, and accelerated time to insight.

This executive summary distills the fundamental drivers, transformative shifts, segmentation revelations, and regional nuances shaping the capillary column landscape. It also examines the implications of evolving trade policies, benchmarks leading industry stakeholders, proposes actionable recommendations for strategic advantage, and outlines the research methodology employed. Collectively, these elements provide a comprehensive foundation for informed decision-making and strategic planning in the biopharmaceutical capillary column domain.

Evolving Technological Innovations and Regulatory Dynamics Reshaping Capillary Column Applications in Biopharmaceutical Research and Quality Assurance

The capillary column sphere is witnessing a wave of technological breakthroughs that are redefining separation science. Novel ionic liquid and polymer-based stationary phases have emerged, delivering unique selectivities for challenging analytes such as polar metabolites and complex peptides. At the same time, metal oxide-coated columns are gaining traction for their robust chemical resistance and extended lifespan in rigorous purification protocols.

Concurrently, regulatory landscapes are adapting to the intricacies of high-potency and biologic therapeutics. Stringent guidelines on assay validation and stability testing are compelling practitioners to adopt columns capable of unparalleled reproducibility, while method development workflows increasingly leverage machine learning algorithms to streamline optimization cycles. The convergence of digitalization and automation has further accelerated the pace at which method parameters are fine-tuned, ensuring alignment with evolving compliance requirements.

Ultimately, sustainability considerations are reshaping materials selection and waste management practices. Advances in reusable column formats and solvent-reduction techniques are responding to mounting environmental expectations. As a result, the trajectory of capillary column innovation is characterized by an intricate interplay of scientific creativity, regulatory responsiveness, and ecological stewardship.

Assessing the Far-Reaching Consequences of 2025 US Tariff Adjustments on Biopharmaceutical Capillary Column Supply Chains and Costs

Beginning in early 2025, a series of tariff adjustments instituted by the United States government introduced new complexities for the global capillary column supply chain. Manufacturers relying on imported fused silica, advanced stationary phases, and precision-engineered metal components encountered elevated cost pressures. These developments prompted strategic reassessments of procurement channels, with many stakeholders pivoting toward domestic sourcing partnerships and regional distribution centers.

Moreover, the tariff shifts underscored the importance of production agility. Laboratory operators have accelerated qualification processes for alternate column suppliers, ensuring that method transfer and validation timelines remain uncompromised. In parallel, companies have reassessed inventory management practices to buffer against potential logistical delays, balancing the costs of carryover stock with the risks of supply disruptions.

As these dynamics evolve, the overarching impact extends beyond immediate cost implications. The heightened focus on supply chain resilience is fostering deeper collaboration between column producers and end-users, yielding co-development initiatives aimed at customizing column chemistries and formats. These strategic alliances serve to mitigate future trade-related uncertainties and reinforce the foundation for uninterrupted analytical operations.

Deriving Actionable Insights from Multidimensional Segmentation of Capillary Column Markets in Biopharma Analysis and Development

Segmentation by application reveals a multifaceted market where bioanalysis demands precise quantitation of target analytes, metabolite profiling focuses on comprehensive trace detection, and purity analysis targets high-fidelity separation of structurally similar compounds. Quality control practitioners navigate assay validation and stability testing protocols that require columns with consistent performance over extended cycles. In parallel, research and development teams depend on method development to establish robust separation criteria and on method optimization to refine operational parameters for maximum efficiency.

The segmentation based on end user spans academic and research institutions that pioneer foundational analytical techniques, biotech companies scaling innovative biologics, contract research organizations delivering outsourced services, and pharmaceutical companies navigating complex regulatory landscapes. Each user segment imposes distinct technical specifications and operational priorities, ranging from high-throughput screening to rigorous compliance in clinical trial supply testing.

When examining column type selection, fused silica remains a mainstay for routine separations, while metal and polymer formats offer enhanced durability and tailored chemical interactions for niche applications. Particle size choices-1.7 micrometers for ultra-high resolution, 3 micrometers for balanced throughput, and 5 micrometers for cost-effective robustness-further define the resolution-speed spectrum. Column lengths of 10 meters, 15 meters, and 30 meters provide gradations in separation power and analysis time, catering to both extended gradient methods and rapid profiling needs. Finally, stationary phase innovations encompassing ionic liquids, metal oxide layers, polymer-based coatings, and traditional silica-based matrices afford nuanced selectivity profiles for a wide variety of biomolecular targets.

Uncovering Key Regional Drivers Influencing Capillary Column Adoption Across Americas, Europe Middle East & Africa, and Asia-Pacific Biopharmaceutical Hubs

In the Americas, a blend of well-established pharmaceutical hubs and rapidly expanding biotech clusters fuels demand for high-performance capillary columns. Domestic manufacturers are increasingly collaborating with local research institutions to co-develop bespoke column chemistries that meet region-specific regulatory criteria, while distributors emphasize rapid turnaround and technical support to ensure seamless workflow integration.

Within Europe, the Middle East, and Africa, harmonized regulatory frameworks in the European Union drive significant adoption of advanced column technologies, particularly those offering low carryover and enhanced reproducibility. Simultaneously, emerging markets in the Middle East and Africa show growing interest in cost-effective solutions that balance performance with budgetary constraints. Collaborative ventures between European suppliers and regional partners are establishing distribution networks that streamline access and after-sales service.

Asia-Pacific stands out for its dynamic combination of academic excellence, manufacturing prowess, and biotech entrepreneurship. High research intensity in countries such as Japan and South Korea complements expanding manufacturing capabilities in China and India. This convergence fosters accelerated technology transfer, method standardization, and local production of specialized stationary phases, underscoring the region’s pivotal role in shaping future advancements.

Profiling Leading Innovators and Strategic Partnerships Driving Advancements in Biopharmaceutical Capillary Column Technologies Globally

A cohort of established chromatography suppliers and emerging specialty firms is driving the evolution of capillary column technologies. Through strategic partnerships with chemical innovators, proprietary polymer-based and ionic liquid stationary phases are being introduced to address previously intractable separation challenges. Leading instrument vendors are integrating column diagnostics and predictive maintenance algorithms to elevate uptime and analytical throughput.

Collaborative research alliances between column manufacturers and contract research organizations are streamlining method qualification processes, delivering validated protocols that expedite regulatory submissions. Moreover, joint ventures with academic laboratories are fostering the translation of novel stationary phase concepts from bench-scale experimentation to commercial deployment. These symbiotic relationships are amplifying the pace of innovation and expanding the application scope of capillary columns across diverse therapeutic modalities.

Implementing Strategic Roadmaps for Industry Leaders to Optimize Capillary Column Integration and Strengthen Competitive Advantage

To capitalize on emerging opportunities, industry leaders should prioritize the adoption of next-generation stationary phases that deliver enhanced selectivity for complex biomolecules while maintaining long-term stability under rigorous operating conditions. Simultaneously, integrating digital tools for predictive maintenance and automated method optimization can reduce downtime and accelerate time to insight.

Strengthening supply chain resilience is equally imperative; establishing regional distribution alliances and qualifying multiple column sources will mitigate risks associated with trade policy fluctuations. Incorporating sustainability into column design-through reusable formats and low-solvent protocols-will position organizations to meet evolving environmental regulations and stakeholder expectations. Finally, fostering cross-sector collaborations between column developers, instrument manufacturers, and end-users will unlock co-development pathways, ensuring that next-generation capillary column solutions are aligned with real-world biopharmaceutical challenges.

Employing Rigorous Hybrid Research Methodologies to Ensure Robust Insights Into Capillary Column Utilization Across Biopharmaceutical Applications

The research methodology underpinning this analysis employs a hybrid approach, combining primary interviews with subject matter experts and senior analysts from biopharmaceutical organizations with rigorous secondary research from peer-reviewed journals, industry white papers, and technical symposia proceedings. This dual approach ensures that quantitative observations are contextualized within the latest scientific developments and real-world operational experiences.

Data triangulation techniques are applied throughout, cross-referencing insights from equipment manufacturers, column producers, academic institutions, and end-user facilities. Consistent validation checkpoints and iterative review cycles guarantee that anomalies are addressed and emerging trends are substantiated. Ultimately, this robust framework delivers a comprehensive, balanced perspective on the multifaceted factors influencing capillary column utilization in biopharmaceutical contexts.

Synthesizing Critical Findings to Shape the Future Trajectory of Capillary Column Technologies in Biopharmaceutical Development

This executive summary has illuminated the critical interplay between technological innovation, regulatory adaptation, and supply chain dynamics in shaping the capillary column landscape. By dissecting the nuanced demands of diverse applications and end-user segments, stakeholders can tailor column specifications to maximize analytical performance and operational resilience.

Regional analyses reveal that strategic collaborations and localized production capabilities are pivotal in maintaining continuity and cost-effectiveness amidst evolving trade environments. Moreover, profiling leading companies underscores the importance of cross-sector partnerships in accelerating the translation of novel stationary phase chemistries into commercially viable solutions.

Looking ahead, organizations that proactively integrate sustainable practices, digital optimization tools, and multi-sourced supply strategies will be best positioned to navigate the complexities of advanced biopharmaceutical separations. The insights contained within this summary provide a roadmap for informed decision-making and strategic investment, ensuring that capillary column technologies continue to enable breakthroughs in drug discovery, development, and manufacturing.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Application
    • Bioanalysis
    • Metabolite Profiling
    • Purity Analysis
    • Quality Control
      • Assay Validation
      • Stability Testing
    • Research And Development
      • Method Development
      • Method Optimization
  • End User
    • Academic And Research Institutions
    • Biotech Companies
    • Contract Research Organizations
    • Pharmaceutical Companies
  • Column Type
    • Fused Silica
    • Metal
    • Polymer
  • Particle Size
    • 1.7 µm
    • 3 µm
    • 5 µm
  • Column Length
    • 10 m
    • 15 m
    • 30 m
  • Stationary Phase
    • Ionic Liquid
    • Metal Oxide
    • Polymer-Based
    • Silica-Based
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific Inc.
  • Waters Corporation
  • Shimadzu Corporation
  • Restek Corporation
  • Merck KGaA
  • PerkinElmer, Inc.
  • GL Sciences Inc.
  • Trajan Scientific and Medical Pty Ltd
  • SGE Analytical Science Pty Ltd

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Development of ultra-high-pressure capillary columns for rapid monoclonal antibody separation
5.2. Emergence of silicon-based microstructured capillary columns for enhanced biomolecule resolution
5.3. Adoption of column surface chemistries tailored for glycoprotein and peptide variant profiling
5.4. Integration of capillary columns with mass spectrometry workflows for biopharmaceutical impurity analysis
5.5. Utilization of 3D-printed capillary column housings to reduce manufacturing costs and customization
5.6. Advancements in temperature-programmed capillary column technology for improved protein stability assays
5.7. Growth of regulatory guidance driving standardized validation protocols for biopharma capillary columns
5.8. Rise of polymer-based stationary phases in capillary columns to improve biomolecular separation performance
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Capillary Columns for Biopharmaceuticals Market, by Application
8.1. Introduction
8.2. Bioanalysis
8.3. Metabolite Profiling
8.4. Purity Analysis
8.5. Quality Control
8.5.1. Assay Validation
8.5.2. Stability Testing
8.6. Research And Development
8.6.1. Method Development
8.6.2. Method Optimization
9. Capillary Columns for Biopharmaceuticals Market, by End User
9.1. Introduction
9.2. Academic And Research Institutions
9.3. Biotech Companies
9.4. Contract Research Organizations
9.5. Pharmaceutical Companies
10. Capillary Columns for Biopharmaceuticals Market, by Column Type
10.1. Introduction
10.2. Fused Silica
10.3. Metal
10.4. Polymer
11. Capillary Columns for Biopharmaceuticals Market, by Particle Size
11.1. Introduction
11.2. 1.7 µm
11.3. 3 µm
11.4. 5 µm
12. Capillary Columns for Biopharmaceuticals Market, by Column Length
12.1. Introduction
12.2. 10 m
12.3. 15 m
12.4. 30 m
13. Capillary Columns for Biopharmaceuticals Market, by Stationary Phase
13.1. Introduction
13.2. Ionic Liquid
13.3. Metal Oxide
13.4. Polymer-Based
13.5. Silica-Based
14. Americas Capillary Columns for Biopharmaceuticals Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Capillary Columns for Biopharmaceuticals Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Capillary Columns for Biopharmaceuticals Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Agilent Technologies, Inc.
17.3.2. Thermo Fisher Scientific Inc.
17.3.3. Waters Corporation
17.3.4. Shimadzu Corporation
17.3.5. Restek Corporation
17.3.6. Merck KGaA
17.3.7. PerkinElmer, Inc.
17.3.8. GL Sciences Inc.
17.3.9. Trajan Scientific and Medical Pty Ltd
17.3.10. SGE Analytical Science Pty Ltd
18. Research AI19. Research Statistics20. Research Contacts21. Research Articles22. Appendix
List of Figures
FIGURE 1. CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PARTICLE SIZE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PARTICLE SIZE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN LENGTH, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN LENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATIONARY PHASE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATIONARY PHASE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET: RESEARCHAI
FIGURE 28. CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET: RESEARCHSTATISTICS
FIGURE 29. CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET: RESEARCHCONTACTS
FIGURE 30. CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY BIOANALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY BIOANALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY METABOLITE PROFILING, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY METABOLITE PROFILING, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PURITY ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PURITY ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY QUALITY CONTROL, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY QUALITY CONTROL, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY ASSAY VALIDATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY ASSAY VALIDATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STABILITY TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STABILITY TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY QUALITY CONTROL, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY QUALITY CONTROL, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY METHOD DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY METHOD DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY METHOD OPTIMIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY METHOD OPTIMIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN TYPE, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN TYPE, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY FUSED SILICA, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY FUSED SILICA, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY METAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY METAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY POLYMER, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY POLYMER, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PARTICLE SIZE, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PARTICLE SIZE, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY 1.7 ?M, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY 1.7 ?M, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY 3 ?M, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY 3 ?M, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY 5 ?M, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY 5 ?M, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN LENGTH, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN LENGTH, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY 10 M, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY 10 M, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY 15 M, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY 15 M, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY 30 M, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY 30 M, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATIONARY PHASE, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATIONARY PHASE, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY IONIC LIQUID, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY IONIC LIQUID, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY METAL OXIDE, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY METAL OXIDE, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY POLYMER-BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY POLYMER-BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY SILICA-BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY SILICA-BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY QUALITY CONTROL, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY QUALITY CONTROL, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN TYPE, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN TYPE, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PARTICLE SIZE, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PARTICLE SIZE, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN LENGTH, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN LENGTH, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATIONARY PHASE, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATIONARY PHASE, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY QUALITY CONTROL, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY QUALITY CONTROL, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN TYPE, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN TYPE, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PARTICLE SIZE, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PARTICLE SIZE, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN LENGTH, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN LENGTH, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATIONARY PHASE, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATIONARY PHASE, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 113. CANADA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 114. CANADA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 115. CANADA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY QUALITY CONTROL, 2018-2024 (USD MILLION)
TABLE 116. CANADA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY QUALITY CONTROL, 2025-2030 (USD MILLION)
TABLE 117. CANADA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 118. CANADA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 119. CANADA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. CANADA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. CANADA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN TYPE, 2018-2024 (USD MILLION)
TABLE 122. CANADA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN TYPE, 2025-2030 (USD MILLION)
TABLE 123. CANADA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PARTICLE SIZE, 2018-2024 (USD MILLION)
TABLE 124. CANADA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PARTICLE SIZE, 2025-2030 (USD MILLION)
TABLE 125. CANADA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN LENGTH, 2018-2024 (USD MILLION)
TABLE 126. CANADA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN LENGTH, 2025-2030 (USD MILLION)
TABLE 127. CANADA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATIONARY PHASE, 2018-2024 (USD MILLION)
TABLE 128. CANADA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATIONARY PHASE, 2025-2030 (USD MILLION)
TABLE 129. MEXICO CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 130. MEXICO CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 131. MEXICO CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY QUALITY CONTROL, 2018-2024 (USD MILLION)
TABLE 132. MEXICO CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY QUALITY CONTROL, 2025-2030 (USD MILLION)
TABLE 133. MEXICO CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 134. MEXICO CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 135. MEXICO CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. MEXICO CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. MEXICO CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN TYPE, 2018-2024 (USD MILLION)
TABLE 138. MEXICO CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN TYPE, 2025-2030 (USD MILLION)
TABLE 139. MEXICO CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PARTICLE SIZE, 2018-2024 (USD MILLION)
TABLE 140. MEXICO CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PARTICLE SIZE, 2025-2030 (USD MILLION)
TABLE 141. MEXICO CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN LENGTH, 2018-2024 (USD MILLION)
TABLE 142. MEXICO CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN LENGTH, 2025-2030 (USD MILLION)
TABLE 143. MEXICO CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATIONARY PHASE, 2018-2024 (USD MILLION)
TABLE 144. MEXICO CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATIONARY PHASE, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY QUALITY CONTROL, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY QUALITY CONTROL, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN TYPE, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN TYPE, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PARTICLE SIZE, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PARTICLE SIZE, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN LENGTH, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN LENGTH, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATIONARY PHASE, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATIONARY PHASE, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY QUALITY CONTROL, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY QUALITY CONTROL, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN TYPE, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN TYPE, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PARTICLE SIZE, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PARTICLE SIZE, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN LENGTH, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN LENGTH, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATIONARY PHASE, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATIONARY PHASE, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY QUALITY CONTROL, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY QUALITY CONTROL, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN TYPE, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN TYPE, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PARTICLE SIZE, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PARTICLE SIZE, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN LENGTH, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN LENGTH, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATIONARY PHASE, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATIONARY PHASE, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY QUALITY CONTROL, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY QUALITY CONTROL, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 202. UNITED KINGDOM CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN TYPE, 2018-2024 (USD MILLION)
TABLE 204. UNITED KINGDOM CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN TYPE, 2025-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PARTICLE SIZE, 2018-2024 (USD MILLION)
TABLE 206. UNITED KINGDOM CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PARTICLE SIZE, 2025-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN LENGTH, 2018-2024 (USD MILLION)
TABLE 208. UNITED KINGDOM CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN LENGTH, 2025-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATIONARY PHASE, 2018-2024 (USD MILLION)
TABLE 210. UNITED KINGDOM CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATIONARY PHASE, 2025-2030 (USD MILLION)
TABLE 211. GERMANY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 212. GERMANY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 213. GERMANY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY QUALITY CONTROL, 2018-2024 (USD MILLION)
TABLE 214. GERMANY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY QUALITY CONTROL, 2025-2030 (USD MILLION)
TABLE 215. GERMANY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 216. GERMANY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 217. GERMANY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. GERMANY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. GERMANY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN TYPE, 2018-2024 (USD MILLION)
TABLE 220. GERMANY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN TYPE, 2025-2030 (USD MILLION)
TABLE 221. GERMANY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PARTICLE SIZE, 2018-2024 (USD MILLION)
TABLE 222. GERMANY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PARTICLE SIZE, 2025-2030 (USD MILLION)
TABLE 223. GERMANY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN LENGTH, 2018-2024 (USD MILLION)
TABLE 224. GERMANY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN LENGTH, 2025-2030 (USD MILLION)
TABLE 225. GERMANY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATIONARY PHASE, 2018-2024 (USD MILLION)
TABLE 226. GERMANY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATIONARY PHASE, 2025-2030 (USD MILLION)
TABLE 227. FRANCE CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 228. FRANCE CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 229. FRANCE CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY QUALITY CONTROL, 2018-2024 (USD MILLION)
TABLE 230. FRANCE CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY QUALITY CONTROL, 2025-2030 (USD MILLION)
TABLE 231. FRANCE CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 232. FRANCE CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 233. FRANCE CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. FRANCE CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. FRANCE CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN TYPE, 2018-2024 (USD MILLION)
TABLE 236. FRANCE CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN TYPE, 2025-2030 (USD MILLION)
TABLE 237. FRANCE CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PARTICLE SIZE, 2018-2024 (USD MILLION)
TABLE 238. FRANCE CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PARTICLE SIZE, 2025-2030 (USD MILLION)
TABLE 239. FRANCE CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN LENGTH, 2018-2024 (USD MILLION)
TABLE 240. FRANCE CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN LENGTH, 2025-2030 (USD MILLION)
TABLE 241. FRANCE CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATIONARY PHASE, 2018-2024 (USD MILLION)
TABLE 242. FRANCE CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATIONARY PHASE, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY QUALITY CONTROL, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY QUALITY CONTROL, 2025-2030 (USD MILLION)
TABLE 247. RUSSIA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 248. RUSSIA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 249. RUSSIA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 250. RUSSIA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 251. RUSSIA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN TYPE, 2018-2024 (USD MILLION)
TABLE 252. RUSSIA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN TYPE, 2025-2030 (USD MILLION)
TABLE 253. RUSSIA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PARTICLE SIZE, 2018-2024 (USD MILLION)
TABLE 254. RUSSIA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PARTICLE SIZE, 2025-2030 (USD MILLION)
TABLE 255. RUSSIA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN LENGTH, 2018-2024 (USD MILLION)
TABLE 256. RUSSIA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN LENGTH, 2025-2030 (USD MILLION)
TABLE 257. RUSSIA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATIONARY PHASE, 2018-2024 (USD MILLION)
TABLE 258. RUSSIA CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATIONARY PHASE, 2025-2030 (USD MILLION)
TABLE 259. ITALY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 260. ITALY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 261. ITALY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY QUALITY CONTROL, 2018-2024 (USD MILLION)
TABLE 262. ITALY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY QUALITY CONTROL, 2025-2030 (USD MILLION)
TABLE 263. ITALY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 264. ITALY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 265. ITALY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. ITALY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. ITALY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN TYPE, 2018-2024 (USD MILLION)
TABLE 268. ITALY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN TYPE, 2025-2030 (USD MILLION)
TABLE 269. ITALY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PARTICLE SIZE, 2018-2024 (USD MILLION)
TABLE 270. ITALY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY PARTICLE SIZE, 2025-2030 (USD MILLION)
TABLE 271. ITALY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN LENGTH, 2018-2024 (USD MILLION)
TABLE 272. ITALY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY COLUMN LENGTH, 2025-2030 (USD MILLION)
TABLE 273. ITALY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATIONARY PHASE, 2018-2024 (USD MILLION)
TABLE 274. ITALY CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY STATIONARY PHASE, 2025-2030 (USD MILLION)
TABLE 275. SPAIN CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 276. SPAIN CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 277. SPAIN CAPILLARY COLUMNS FOR BIOPHARMACEUTICALS MARKET SIZE, BY Q

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Capillary Columns for Biopharmaceuticals Market report include:
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific Inc.
  • Waters Corporation
  • Shimadzu Corporation
  • Restek Corporation
  • Merck KGaA
  • PerkinElmer, Inc.
  • GL Sciences Inc.
  • Trajan Scientific and Medical Pty Ltd
  • SGE Analytical Science Pty Ltd

Related Topics

Related Reports

Biopharmaceutical Process Analytical Technology Market by Product Type (Analyzers, Sensors & Probes, Software & Services), Technology (Capillary Electrophoresis, Chromatography, Particle Analysis), Measurement Type, Process Stage, End User - Global Forecast 2025-2030 - Product Image

Biopharmaceutical Process Analytical Technology Market by Product Type (Analyzers, Sensors & Probes, Software & Services), Technology (Capillary Electrophoresis, Chromatography, Particle Analysis), Measurement Type, Process Stage, End User - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
Biopharmaceutical Bioseparation Systems Market by Product Type, Application, End User, Operation Mode - Global Forecast 2025-2030 - Product Image

Biopharmaceutical Bioseparation Systems Market by Product Type, Application, End User, Operation Mode - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
Global Biopharma Chromatography Systems Market Size, Share, Trend, Forecast, Competitive Analysis, and Growth Opportunity: 2024-2030 - Product Image

Global Biopharma Chromatography Systems Market Size, Share, Trend, Forecast, Competitive Analysis, and Growth Opportunity: 2024-2030

  • Report
  • 116 Pages
  • Global
From
Biopharmaceutical Fermentation - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Biopharmaceutical Fermentation - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 110 Pages
  • Global
From
Biopharmaceutical Bioseparation Systems - Global Strategic Business Report - Product Image

Biopharmaceutical Bioseparation Systems - Global Strategic Business Report

  • Report
  • 360 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.